STOCK TITAN
  1. Home
  2. CALTX

Six Circles Multi-Strategy Stock Price, News & Analysis

CALTX

Company Description

Six Circles Multi-Strategy (Nasdaq: CALTX) is a publicly traded company.

CALTX stock has gained 0.0% over the past year.

This page provides a comprehensive overview of CALTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
July 26, 2024
0.00%

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

June 18, 2024
0.00%

Calliditas provides setanaxib patent update

May 30, 2024
0.00%

Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy

May 28, 2024
0.00%

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

May 23, 2024
0.00%

Calliditas Q1 report, January - March 2024

earnings
May 16, 2024
0.00%

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

Six Circles Multi-Strategy has 10 recent news articles. Key topics include earnings, conferences, clinical trial. View all CALTX news →

SEC Filings

View All

No SEC filings available for CALTX.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months